MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with G

Granisetron

Granisetron 1mg tablets

Use with caution

Stability notes for Granisetron 1mg tablets

Protect from light.

Provenance

This compatibility recommendation is derived from Kytril 1mg tablets (Atnahs Pharma UK Ltd).

Suppliers (8) of Granisetron 1mg tablets
Granisetron 1mg tablets (A A H Pharmaceuticals Ltd)
Granisetron 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Granisetron 1mg tablets (Crescent Pharma Ltd)
Granisetron 1mg tablets (Phoenix Healthcare Distribution Ltd)
Granisetron 1mg tablets (Torrent Pharma (UK) Ltd)
Granisetron 1mg tablets (Viatris UK Healthcare Ltd)
Kytril 1mg tablets (Atnahs Pharma UK Ltd)
Kytril 1mg tablets (Sigma Pharmaceuticals Plc)

Granisetron 3.1mg/24hours transdermal patches

No stability information

Stability notes for Granisetron 3.1mg/24hours transdermal patches

There are no stability notes for this medicine.

Supplier

Sancuso 3.1mg/24hours transdermal patches (Grunenthal Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.